Other studies demonstrated that some antiparkinsonian drugs such as dopamine receptor agonists and MAO-B inhibitors like selegiline and rasagiline, when administered in the recommended dose range for the treatment of PD, exerted limited antidepressant efficacy in patients with PD [52,82,83,84,85,86,87,88,89]. Here, MAOB is linked to Parkinson disease.